🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Sankalp Arora

The University of Texas MD Anderson Cancer Center

ORCID: 0000-0002-8162-4119
MedicineComputer ScienceEngineering

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Adequate assessment yields appropriate care—the role of geriatric assessment and management in older adults with cancer: a position paper from the ESMO/SIOG Cancer in the Elderly Working Group”.

Adequate assessment yields appropriate care—the role of geriatric assessment and management in older adults with cancer: a position paper from the ESMO/SIOG Cancer in the Elderly Working Group

ESMO Open(2024)10.1016/j.esmoop.2024.103657
N/A
0.644DataRank · unranked
72 citations

Gábor Liposits, Sankalp Arora, Nina Rosa Neuendorff, Fábio Gomes, Jessica L. Krok‐Schoen +13 more

Differences in pretreatment frailty across gastrointestinal (GI) cancers in older adults: Results from the Cancer and Aging Resilience Evaluation (CARE) registry.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.4_suppl.542
N/A
0DataRank · unranked
0 citations

Mackenzie E. Fowler, Christian Harmon, Mustafa Al‐Obaidi, Darryl Outlaw, Robert H. Hollis +5 more

Rural-urban disparities in mortality and geriatric assessment among older adults with cancer: The cancer & aging resilience evaluation (CARE) registry

Journal of Geriatric Oncology(2023)10.1016/j.jgo.2023.101505
N/A
0DataRank · unranked
10 citations

Kelly Kenzik, Mustafa Al‐Obaidi, Christian Harmon, Smith Giri, Sankalp Arora +6 more

Rural-urban disparities in Geriatric Assessment (GA) impairments and mortality among older adults with cancer: Results from the Cancer and Aging Resilience Evaluation (CARE) Registry.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.12012
N/A
0DataRank · unranked
1 citations

Kelly Kenzik, Mustafa Al‐Obaidi, Christian Harmon, Smith Giri, Sankalp Arora +5 more

Investigational drugs in early phase trials for myelofibrosis

Expert Opinion on Investigational Drugs(2024)10.1080/13543784.2024.2434696
N/A
0DataRank · unranked
2 citations

Pankit Vachhani, Prithviraj Bose, Sankalp Arora

Phase 1b/2 Study of Magrolimab (Magro), Azacitidine (AZA) and Venetoclax (VEN) in Patients (pts) with Newly Diagnosed (ND) Older/Unfit or High Risk Acute Myeloid Leukemia (AML) and Relapsed Refractory (R/R) AML: Final Clinical Data and Genomic Markers of Resistance/Relapse

Blood(2024)10.1182/blood-2024-203706
N/A
0DataRank · unranked
5 citations

Jayastu Senapati, Sanam Loghavi, Patrick K. Reville, Bofei Wang, Tapan M. Kadia +21 more

Azacitidine, Venetoclax, and Magrolimab in Newly Diagnosed and Relapsed Refractory Acute Myeloid Leukemia: Phase Ib/II Study and Correlative Analysis

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-25-0229
N/A
0DataRank · unranked
15 citations

Jayastu Senapati, Hagop M. Kantarjian, Bofei Wang, Patrick K. Reville, Sanam Loghavi +21 more